Inactive Instrument

News Cipher Pharmaceuticals Inc Nasdaq

Equities

CA17253X1050

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Cipher Pharmaceuticals Downgraded to Hold at Stifel GMP Following Share-Price Gains; Price Target Raised to C$9.50	05-13	MT
Transcript : Cipher Pharmaceuticals Inc., Q1 2024 Earnings Call, May 10, 2024	05-10
Cipher Pharmaceuticals : Financial Document	05-10	PU
Cipher Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-09	CI
Cipher Pharmaceuticals Reports First Quarter 2024 Results	05-09	AQ
Cipher Pharmaceuticals Schedules Q1 2024 Earnings Release and Conference Call	05-06	AQ
Cipher Pharmaceuticals Schedules Q1 2024 Earnings Release and Conference Call	05-03	AQ
Cipher Pharmaceuticals Announces Participation in the 2024 Bloom Burton & Co. Healthcare Investor Conference	04-03	NE
Transcript : Cipher Pharmaceuticals Inc., Q4 2023 Earnings Call, Mar 15, 2024	03-15
Tranche Update on Cipher Pharmaceuticals Inc.'s Equity Buyback Plan announced on November 15, 2023.	03-14	CI
Cipher Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-14	CI
Cipher Pharmaceuticals Q4 Profit Falls 61% on Charges	03-14	MT
Cipher Pharmaceuticals Brief: Q4 Net income and earnings per common share were US$7.7 million and $0.32, respectively	03-14	MT
Cipher Pharmaceuticals Brief: Q4 Total revenue was US$4.9 million, consistent with Q4 2022	03-14	MT
Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results	03-14	AQ
Cipher Pharmaceuticals Schedules Q4 2023 Earnings Release and Conference Call	03-08	AQ
Cipher Pharmaceuticals Upgraded to Buy at Stifel GMP; Price Target Raised to C$8.00	02-14	MT
Cipher Pharmaceuticals Brief: Announcing that its common shares are now trading on the OTCQX Best Market	01-29	MT
Cipher Pharmaceuticals Announces the Commencement of OTCQX Trading	01-29	AQ
Cipher Pharmaceuticals Announces Change of Auditor	11-27	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Cipher Pharmaceuticals Inc Nasdaq

Equities

CA17253X1050

Summary

Filters